Evaluation of SARS-CoV-2 Vaccine-Induced Antibody Responses in Patients with Neuroimmunological Disorders: A Real-World Experience
Hyunjin Ju(Samsung Medical Center), Byoung Joon Kim(Samsung Medical Center), Jin Myoung Seok(Samsung Medical Center), Yeon Hak Chung(Samsung Medical Center), Mi Young Jeon(Samsung Medical Center), Soonwook Kwon(Inha University Hospital), Sun‐Young Kim(Hanyang Cyber University), Hye Lim Lee(Korea University Medical Center), Ju‐Hong Min(Samsung Medical Center)
Cited by 0
Related Papers
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
|Multiple Sclerosis Journal|2011|284
The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders
|Multiple Sclerosis Journal|2013|84
Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea
|Multiple Sclerosis Journal|2017|82
Oral Solubilized Ursodeoxycholic Acid Therapy in Amyotrophic Lateral Sclerosis: A Randomized Cross-Over Trial
|Journal of Korean Medical Science|2012|58